NLRP3 and colorectal cancer: Therefore, it is not surprising that delineation of molecular cross-talk between activation of NLRP3 inflammasomes and EMT-associated markers has become the center of research attention and can be an attractive strategy for reducing the risk of colorectal cancer progression.